Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

Similar articles for PubMed (Select 23354589)

1.

A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy.

Dai L, Liu Y, Liu J, Wen X, Xu Z, Wang Z, Sun H, Tang S, Maguire AR, Quan J, Zhang H, Ye T.

Cancer Lett. 2013 Jun 1;333(1):103-12. doi: 10.1016/j.canlet.2013.01.025. Epub 2013 Jan 24.

PMID:
23354589
2.

Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.

Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.

Blood. 2000 Oct 15;96(8):2746-54.

3.
4.

Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.

Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S, Budillon A.

J Cell Physiol. 2003 Apr;195(1):139-50.

PMID:
12599217
5.
7.

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.

Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.

Oncogene. 1999 May 6;18(18):2798-810.

8.

Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.

Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.

Exp Cell Res. 1999 Feb 25;247(1):189-99.

PMID:
10047461
9.

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.

Reynisdóttir I, Polyak K, Iavarone A, Massagué J.

Genes Dev. 1995 Aug 1;9(15):1831-45.

11.

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).

Greeve MA, Allan RK, Harvey JM, Bentel JM.

J Mol Endocrinol. 2004 Jun;32(3):793-810.

12.

Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.

Halfter H, Friedrich M, Resch A, Kullmann M, Stögbauer F, Ringelstein EB, Hengst L.

Cancer Res. 2006 Jul 1;66(13):6530-9.

13.

Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.

Swarbrick A, Lee CS, Sutherland RL, Musgrove EA.

Mol Cell Biol. 2000 Apr;20(7):2581-91.

14.
15.

A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.

Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E, Roberts JM.

Curr Biol. 1999 Feb 25;9(4):163-73.

16.

Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2.

Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL.

J Biol Chem. 2001 Dec 14;276(50):47675-83. Epub 2001 Oct 4.

18.
19.

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Vlach J, Hennecke S, Amati B.

EMBO J. 1997 Sep 1;16(17):5334-44.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk